Transport of Six Tyrosine Kinase Inhibitors: Active or Passive?

ADMET and DMPK - Croatia
doi 10.5599/admet.4.1.275
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Association of Physical Chemists (IAPC)

Related search

ABCB1 Haplotypes Do Not Influence Transport or Efficacy of Tyrosine Kinase Inhibitors in Vitro

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2013English

Personalized Therapy of Tyrosine Kinase Inhibitors

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
2013English

Tyrosine Kinase Inhibitors for Diabetes

Science-Business eXchange
2008English

Tyrosine Kinase Inhibitors in Lung Cancer

Hematology/Oncology Clinics of North America
OncologyHematology
2012English

Small Molecule FLT3 Tyrosine Kinase Inhibitors

2012English

Tyrosine Kinase Inhibitors in Advanced Thyroid Cancer

Journal of the Siena Academy of Sciences
2012English

Invasive Aspergillosis Complicating Treatment With Tyrosine Kinase Inhibitors

BMJ Case Reports
Medicine
2019English

Tyrosine Kinase Inhibitors: A Foe for the Thyroid?

Journal of Endocrinology and Thyroid Research
2017English

Small Molecule Tyrosine Kinase Inhibitors in Pancreatic Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy